🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy...
Status
Completed
Location
Piedmont Cancer Institute, P.C.
Start Date
2019-12-05
Trial ID
NCT04179396
Treatments Being Tested
By incorporating dual-tracer PET/CT (PSMA and FDG) and ctDNA, we aimed to e...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-07-15
Trial ID
NCT05188911
Treatments Being Tested
This phase II trial studies how well the combination of apalutamide, abirat...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2020-05-11
Trial ID
NCT04267887
This is a prospective, open-label, multi-center seamless phase II to phase ...
Status
Recruiting
Location
VA Long Beach Healthcare System, Long Beach, CA
Start Date
2021-07-01
Trial ID
NCT04787744
Treatments Being Tested
This research study is comparing two different combinations of androgen dep...
Status
Unknown
Location
University of California, San Diego
Start Date
2017-11-24
Trial ID
NCT03141671
Treatments Being Tested
This phase II trial studies the effect of talazoparib with androgen depriva...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2021-05-04
Trial ID
NCT04734730
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antiand...
Status
Completed
Location
NEA Medical Clinic - East Matthews
Start Date
2011-08-09
Trial ID
NCT01309672
Treatments Being Tested
This phase II trial studies how well antiandrogen therapy, abiraterone acet...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-06-29
Trial ID
NCT03649841
Treatments Being Tested